Invitation to the presentation of Recipharm’s interim report January - June 2019

Recipharm AB will publish its interim report for January - June 2019 on 25th July at 07:45 am CET.

The company invites investors, analysts and media to a web conference (in English) on 25 July at 10:00 am CET, where CEO Thomas Eldered and CFO Tobias Hägglöv will present and comment on the report as well as answer questions.

The report will be available on Recipharm’s website www.recipharm.com/investor-relations from 7:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 25th July.

To participate in the web conference, please use the below link:

https://webinars.on24.com/EMEA/RecipharmQ2_2019

Questions may be submitted by dialing below telephone numbers during the conference. If you don’t wish to ask questions by telephone you only need to participate through the link above.

From Sweden: +46 8 566 426 51
From France: + 33 170 750 711
From Germany: +49 691 380 34 30
From India: +91 226 187 51 27
From Israel: +972 372 076 79
From Italy: +39 023 601 38 21
From Portugal: +351 210 609 105
From Spain: +34 935 472 900
From the UK: +44 333 300 08 04
From the USA: +1 631 913 14 22

Pin code for participants:
68033027#

For more information, please contact:
ir@recipharm.com, telephone: +46 8 602 52 00

Recipharm AB (publ)
Corporate identity number 556498-8425
Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00
www.recipharm.com